Aflibercept (VEGF Trap) - HY-108801A
Nur noch %1 verfügbar
Catalog #
HY-108801A
Ab
548,00 €
Aflibercept (VEGF Trap) is a soluble decoy VEGFR constructed by fusing the Ig domains of VEGFR1 and VEGFR2 with the Fc region of human IgG1. Aflibercept inhibits VEGF signaling by reducing VEGF-regulated processes. Aflibercept can be used for thr research of age-related macular degeneration (AMD) and cardiovascular disease[1][2][3].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-108801A/Aflibercept-VEGF-Trap-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Dry Ice |
| Application | Metabolism-protein/nucleotide metabolism |
| CAS | 862111-32-8 |
| Storage | Store at -80°C for 2 years |
| Solubility | 10 mM in DMSO |
| Clinical Information | Phase 4 |
| Target | VEGFR |
| Application: | Metabolism-protein/nucleotide metabolism |
|---|